Dinesh K Deelchand1, Kejal Kantarci2, Gülin Öz1. 1. Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA. 2. Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
PURPOSE: To investigate the utility of an advanced magnetic resonance spectroscopy (MRS) protocol in the clinical setting, and to compare the localization accuracy, spectral quality, and quantification repeatability between this advanced and the conventional vendor-provided MRS protocol on a clinical 3T platform. METHODS: Proton spectra were measured from the posterior cingulate cortices in 30 healthy elderly subjects by clinical MR technologists using a vendor-provided (point resolved spectroscopy with advanced 3D gradient-echo B0 shimming) and an advanced (semi-LASER with FAST(EST)MAP shimming) protocol, in random order. Spectra were quantified with LCModel using standard pipelines for the clinical and research settings, respectively. RESULTS: The advanced protocol outperformed the vendor-provided protocol in localization accuracy (chemical-shift-displacement error: 2.0%/ppm, semi-LASER versus 11.6%/ppm, point resolved spectroscopy), spectral quality (water linewidth: 6.1 ± 1.8 Hz, FAST(EST)MAP versus 10.5 ± 3.7 Hz, 3D gradient echo; P < 7e-6; residual water: 0.08 ± 0.12%, VAPOR versus 0.45 ± 0.50%, WET; P < 2e-5) and within-session repeatability of metabolite concentrations, particularly of low signal-to-noise ratio data with two to eight averages (test-retest coefficients of variance of metabolite concentrations, P < 0.01). Concentrations of J-coupled metabolites such as γ-aminobutyric acid and glutamate were biased when using the default pipeline with simulated macromolecules. CONCLUSIONS: The quality of MRS data can be improved using advanced acquisition and analysis protocols on standard 3T hardware in the clinical setting, which can facilitate robust applications in central nervous system diseases. Magn Reson Med 79:1241-1250, 2018.
PURPOSE: To investigate the utility of an advanced magnetic resonance spectroscopy (MRS) protocol in the clinical setting, and to compare the localization accuracy, spectral quality, and quantification repeatability between this advanced and the conventional vendor-provided MRS protocol on a clinical 3T platform. METHODS: Proton spectra were measured from the posterior cingulate cortices in 30 healthy elderly subjects by clinical MR technologists using a vendor-provided (point resolved spectroscopy with advanced 3D gradient-echo B0 shimming) and an advanced (semi-LASER with FAST(EST)MAP shimming) protocol, in random order. Spectra were quantified with LCModel using standard pipelines for the clinical and research settings, respectively. RESULTS: The advanced protocol outperformed the vendor-provided protocol in localization accuracy (chemical-shift-displacement error: 2.0%/ppm, semi-LASER versus 11.6%/ppm, point resolved spectroscopy), spectral quality (water linewidth: 6.1 ± 1.8 Hz, FAST(EST)MAP versus 10.5 ± 3.7 Hz, 3D gradient echo; P < 7e-6; residual water: 0.08 ± 0.12%, VAPOR versus 0.45 ± 0.50%, WET; P < 2e-5) and within-session repeatability of metabolite concentrations, particularly of low signal-to-noise ratio data with two to eight averages (test-retest coefficients of variance of metabolite concentrations, P < 0.01). Concentrations of J-coupled metabolites such as γ-aminobutyric acid and glutamate were biased when using the default pipeline with simulated macromolecules. CONCLUSIONS: The quality of MRS data can be improved using advanced acquisition and analysis protocols on standard 3T hardware in the clinical setting, which can facilitate robust applications in central nervous system diseases. Magn Reson Med 79:1241-1250, 2018.
Authors: Małgorzata Marjańska; J Riley McCarten; James Hodges; Laura S Hemmy; Andrea Grant; Dinesh K Deelchand; Melissa Terpstra Journal: Neuroscience Date: 2017-05-03 Impact factor: 3.590
Authors: Dinesh Kumar Deelchand; Pierre-François Van de Moortele; Gregor Adriany; Isabelle Iltis; Peter Andersen; John P Strupp; J Thomas Vaughan; Kâmil Uğurbil; Pierre-Gilles Henry Journal: J Magn Reson Date: 2010-06-10 Impact factor: 2.229
Authors: Małgorzata Marjańska; Edward J Auerbach; Romain Valabrègue; Pierre-François Van de Moortele; Gregor Adriany; Michael Garwood Journal: NMR Biomed Date: 2011-07-27 Impact factor: 4.044
Authors: Sandeep K Ganji; Abhishek Banerjee; Aditya M Patel; Yan D Zhao; Ivan E Dimitrov; Jeffrey D Browning; E Sherwood Brown; Elizabeth A Maher; Changho Choi Journal: NMR Biomed Date: 2011-08-15 Impact factor: 4.044
Authors: Aaron T Hess; M Dylan Tisdall; Ovidiu C Andronesi; Ernesta M Meintjes; André J W van der Kouwe Journal: Magn Reson Med Date: 2011-03-04 Impact factor: 4.668
Authors: Brian Keating; Weiran Deng; J Cooper Roddey; Nathan White; Anders Dale; V Andrew Stenger; Thomas Ernst Journal: Magn Reson Med Date: 2010-09 Impact factor: 4.668
Authors: Ivan Tkác; Pierre-Gilles Henry; Peter Andersen; C Dirk Keene; Walter C Low; Rolf Gruetter Journal: Magn Reson Med Date: 2004-09 Impact factor: 4.668
Authors: Olga Voevodskaya; Pia C Sundgren; Olof Strandberg; Henrik Zetterberg; Lennart Minthon; Kaj Blennow; Lars-Olof Wahlund; Eric Westman; Oskar Hansson Journal: Neurology Date: 2016-04-15 Impact factor: 9.910
Authors: Young Woo Park; Dinesh K Deelchand; James M Joers; Brian Hanna; Adam Berrington; Joseph S Gillen; Kejal Kantarci; Brian J Soher; Peter B Barker; HyunWook Park; Gülin Öz; Christophe Lenglet Journal: Magn Reson Med Date: 2018-04-06 Impact factor: 4.668
Authors: Gülin Öz; Dinesh K Deelchand; Jannie P Wijnen; Vladimír Mlynárik; Lijing Xin; Ralf Mekle; Ralph Noeske; Tom W J Scheenen; Ivan Tkáč Journal: NMR Biomed Date: 2020-01-10 Impact factor: 4.044
Authors: Martin Wilson; Ovidiu Andronesi; Peter B Barker; Robert Bartha; Alberto Bizzi; Patrick J Bolan; Kevin M Brindle; In-Young Choi; Cristina Cudalbu; Ulrike Dydak; Uzay E Emir; Ramon G Gonzalez; Stephan Gruber; Rolf Gruetter; Rakesh K Gupta; Arend Heerschap; Anke Henning; Hoby P Hetherington; Petra S Huppi; Ralph E Hurd; Kejal Kantarci; Risto A Kauppinen; Dennis W J Klomp; Roland Kreis; Marijn J Kruiskamp; Martin O Leach; Alexander P Lin; Peter R Luijten; Małgorzata Marjańska; Andrew A Maudsley; Dieter J Meyerhoff; Carolyn E Mountford; Paul G Mullins; James B Murdoch; Sarah J Nelson; Ralph Noeske; Gülin Öz; Julie W Pan; Andrew C Peet; Harish Poptani; Stefan Posse; Eva-Maria Ratai; Nouha Salibi; Tom W J Scheenen; Ian C P Smith; Brian J Soher; Ivan Tkáč; Daniel B Vigneron; Franklyn A Howe Journal: Magn Reson Med Date: 2019-03-28 Impact factor: 4.668
Authors: Dinesh K Deelchand; Pierre-Gilles Henry; James M Joers; Edward J Auerbach; Young Woo Park; Firat Kara; Eva-Maria Ratai; Kejal Kantarci; Gülin Öz Journal: Magn Reson Med Date: 2022-01-28 Impact factor: 4.668
Authors: Dinesh K Deelchand; Adam Berrington; Ralph Noeske; James M Joers; Arvin Arani; Joseph Gillen; Michael Schär; Jon-Fredrik Nielsen; Scott Peltier; Navid Seraji-Bozorgzad; Karl Landheer; Christoph Juchem; Brian J Soher; Douglas C Noll; Kejal Kantarci; Eva M Ratai; Thomas H Mareci; Peter B Barker; Gülin Öz Journal: NMR Biomed Date: 2019-12-18 Impact factor: 4.044
Authors: Dinesh K Deelchand; James M Joers; Adarsh Ravishankar; Tianmeng Lyu; Uzay E Emir; Diane Hutter; Christopher M Gomez; Khalaf O Bushara; Christophe Lenglet; Lynn E Eberly; Gülin Öz Journal: Mov Disord Clin Pract Date: 2019-07-10
Authors: Tomohisa Okada; Hideto Kuribayashi; Lana G Kaiser; Yuta Urushibata; Nouha Salibi; Ravi Teja Seethamraju; Sinyeob Ahn; Dinh Ha Duy Thuy; Koji Fujimoto; Tadashi Isa Journal: Quant Imaging Med Surg Date: 2021-01
Authors: Brenda L Bartnik-Olson; Jeffry R Alger; Talin Babikian; Ashley D Harris; Barbara Holshouser; Ivan I Kirov; Andrew A Maudsley; Paul M Thompson; Emily L Dennis; David F Tate; Elisabeth A Wilde; Alexander Lin Journal: Brain Imaging Behav Date: 2021-04 Impact factor: 3.978